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Aines a Abnhmal Mood Biological investigation of mental illness has been much hampered by ignorance of normal function. However, in 1946 Von Euler reported the presence of noradrenaline in the brain and in 1953 Twarog & Page found serotonin also. Recent work has shown that these and other amines maybe divided into two main groups, Types A and C, with opposing actions. The Type A amines elicit all the phenomena of arousal whereas the Type C amines induce sleep. Specific brain receptors for both groups have been identified and other evidence has shown that the Type A receptor is also concerned with elevation of mood. Detailed discussion will be found elsewhere (Dewhurst 1965 (Dewhurst , 1968a (Dewhurst , 1968b ). In the present paper I wish to consider the application in affective illness.
Before developing these ideas two other views linking amines and affective state will be examined.
Serotonin
Although the hypothesis is rarely made explicit many papers carry the implicit notion that serotonin deficiency is associated with depression.
The evidence for this idea is summarized in Table 1 . No cerebral effects occur after exogenous oral 5-hydroxytryptamine (5-HT) or in the usual carcinoid syndromeswith hypersecretion of 5-HT. This does not mean that 5-HT has no cerebral effects but simply that it does not pass the bloodbrain barrier (BBB) . For these reasons the precursor amino acid of 5-HT has been given, namely 5-hydroxytryptophan (5-HTP), for this is known to pass the blood-brain barrier and is decarboxylated in the brain to serotonin. Kline & Sacks gave 5-HTP to depressed patients andbat first reported improvement (1963) but in a later controlled study were unable to confirm this (Kline et al. 1964) . 5-HTP has also been given to human volunteers but there were no notable psychological effects (Brengelmann et al. 1958) . Ethical considerations limit the dosages in such enquiries and those employed were about one tenth of the dose which produced neurological Table 1 Serotini ad affective illness Affectsexogenous amines Nil on mood orally or systemically Effectsexogenous precursors 5-HTPalklviatesdepression (Kline & Sacks 1963) i,ffectsmood elevating drugs affecting endogenous amines MAOs cause increases in brain 5-HT (Spector et al. 1963) Imipramine potentiates 5-HT (Gyermek & Possemato 1960) Effectsmood lowering drugs affecting endogenous amines Roerpinedepletes 5-HT stores ePtscheroet al. 1"6) Lksiumnincrases deaminated and reducesmnthoxylated catechols (Schildkraut, Schanberg & Kopin 1966) ? Favours MAO attack Correlatesurine 5-HTTezcretionlow in depression (Rodnight 1961) Correlates-CSF 5-hydroxyindoles low in depression (Ashcroft & Sharman 1960 ) 5-HIAA low indepression (Dencker et al. 1966) Correlates-brain Hiid-brain 5-HLA low in depression (Boume et al. 1968) Hind-brain 5-HT low in depression Correlates-metabolism COs productionfrom 5-HTP reduced in depression (Coppen, Shaw & Malleson 1965) 5-HT does not pass BBB (Schanberg 1963) 5-HTP inactive in controlled studies (Kline et al. 1964 , Pare & Sandler 1959 No psychological effect in normals No effects in patients with 5-HTP-secreting tumours 5-HTP does not antagonize reserpine (Carlsson et al. 1957) Tryptamine affected more, NA less No correlation of5-HT and mood (Dewhurst &Pare 1961) Similar action for other amines Similar offect on other amines (Pletscheret al. 1955) ? Similar effect on other amines Tryptamine excretion also low (Rodnight 1961) Also low in schizophrenia (Fotherby etal. 1962) Also low in mania (Denckeret al. 1966) ? Revolving door effect ? Barbiturates (Bonnycastle et al. 1957 ) 5-HT normal in depression in later study (Bourne et al. 1968) Normal in depressioAi in later study (Coppen & Shaw 1967) 5-HTP conversion to 5-HIAA normal in depression (Dewhurst & Pare 1961 , Feldsteinet al. 1965 33Section ofPsychiatry effects in animals (Costa 1960) . A solution to these dilemmas is provided by a small group of carcinoid tumours secreting 5-HTP. Of eight cases collected in 1961, six had no neuropsychiatric disability and the remaining two were fully accountable without invoking 5-HT .
Another type of evidence cited is the change produced in endogenous amines by various pharmacological agents with effects on mood. Monoamine oxidase inhibitors (MAQIs) cause rises in cerebral 5-HT due to diminished destruction and imipramine is supposed to hinder access to the enzyme. On the other hand, reserpine which is sometimes followed by depression causes depletion of 5-HT from the cell and lithium possibly favours monoamine oxidase attack. The problem with this type of evidence is that other amines are affected also and it is difficult to separate the effects. Correlations of amine levels have been popular in human studies and Rodnight showed that 5-HT excretion was diminished in depression. Other amines were also low, such as tryptamine (Rodnight 1961) . Particularly interesting are the studies in CSF and brain. As my co-speaker and his colleagues showed, 5-hydroxyindoles are low in the CSF of depressed patients (Ashcroft & Sharman 1960) . Two years later the same group found a similar low figure in schizophrenia (Fotherby et al. 1962) . More recently, Dencker et al. (1966) found that 5-hydroxyindole acetic acid was low in the CSF of depressed patients but was also low in mania as well. Shaw and his colleagues investigated the 5-HT in the hindbrain of a number of suicides and found that it was low in depression ; this finding was not confirmed in a later study in which he took part, although 5-hydroxyindol-3ylacetic acid (5-HIAA) was found to be low (Bourne etal. 1968 ).
Finally, there have been a number of studies seeking to find a metabolic abnormality of serotonin in depression. Shaw & Coppen originally reported that the production of CO, from 5-HTPwas decreased in depression (Coppen, Shaw & Malleson 1965) , but they were unable to confirm this finding in laterwork (Coppen & Shaw 1967) . Other studies haveexamined theconversion of 5-HT to 5-HIAA in depression and found no difference from normals (Dewhurst & Pare 1961 , Feldstein et al. 1965 . The effects of monoamine oxidase inhibitors on this process have also been studied by giving capsules of 5-HT and measuring 5-HIAA in the eight hours afterwards (Dewhurst & Pare 1961) . The majority of patients showed statistically significant changes in 5-HT metabolism; none of these patients improved.
No doubt different people will draw different conclusions from the whole evidence. I think matters can be simplified by eliminating those reports which could not be confirmed, as well as verified data which are irrelevant or indecisive. If one does this, one may conclude that 5-hydroxyindoles may be low in depression but also may be low in schizophrenia, and, even more important, in mania. This similarity in mania and depression, and the lack of correlation between induced 5-HT changes and affect must indicate that cerebral 5-HT changes are secondary and without causal significance as far as mood is concerned. The cause of the low 5-hydroxyindoles may be various.
It is possible that reduced cerebral metabolism may account for part of the changes as it may do in peripheral tissues. Again, the cause of the illness may be directly responsible for low 5hydroxyindoles and other factors may intervene, such as barbiturates. But whatever the reasons for the low 5-hydroxyindoles, the evidence clearly shows no correlation with affect.
Catecholamines
In contrast to 5-HT, a case for catecholamine involvement has been clearly stated by Schildkraut & Kety (1967) . They have hypothesized that some, if not all, depressions are due to deficiency of catecholamines, particularly noradrenaline, whereas in mania the converse holds.
Before dealing with the evidence presented, I think it is worth while reminding ourselves that we are looking for causes, not effects. There seems to be some confusion in those who support the hypothesis about this. As before, we may consider first the effects of exogenous amines (Table  2) . Intravenous adrenaline has been reported as causing 'anxiety' (Wearn & Sturgis 1919) ; whereas others have found that it accentuates preexisting effect, whether this be anxiety, anger or euphoria, and sometimes no effect on emotion occurs (Schachter & Singer 1962) . Noradrenaline has less effect after intravenous administration (Rothballer 1959) . Neither amine passes the blood-brain barrier (Weil-Malherbe 1960) by the time the changes noted have appeared and they must, therefore, be peripheral in origin. For this reason the amino acid precursor, dopa, has been given because it penetrates the blood-brain barrier and is subsequently decarboxylated to form dopamine and other catecholamines. It produces arousal but this is probably due to a direct amino acid effect as well as the preponderating catecholamine formation in extracerebral tissues which causes alerting via vascular responses. As to mood, although benefit should be expected in depression (if the theory holds), two of three studies done have been negative, including Schildkraut's own (Pare & Sandler 1959 , Klerman et al. 1963 , Turner & Merlis 1964 .
As to antidepressants, monoamine oxidase inhibitors are known to increase brain noradrenaline but they also increase other amine levels. Imipramine is believed to protect nor- Table 2 Csecholamine hypothesis of affective illness Effectsexogenous anines Intravenous adrenaline (A) causes anxiety Intravenous noradrenaline (NA) less effect (Wearn & Sturgis 1919 , Rothballer 1959 Effectsexogenous precursors Dopa induces arousal in humans (Dell 1960) and counteracts psychological effects of reerpinein man (Degkwitz et al. 1960) Tryptophan euphoria attributed to NA released by 5-HTP (Schildkraut 1965) Effectsmood elevating drugs affecting amines MAOIs mcrease brain NA (Spector et al. 1963) Excitement correlates with NA not 5-HT (Spectoretal. 1963) Imipramine reduces cell uptake of H3-NA (Glowinski & Axelrod 1964) Reserpine added to imipramine in imipramine-resistant depression gives benefit (Poldinger 1963) , attributed to NA release Amphetamine depletes brain NA (Pletscher et al. 1955) . Effects attributed to NA release Amphetamine decreases deaminated catechols and increases normetanephrine . Protection of NA from MAO inferred Effectsmood lowering drugs affecting endogenous amines Reserpine and tetrabenazine may cause depression (Harris 1957 ) and depleteNA (Pletscher et al. 1955) a-methyltyrosine blocks amphetamine stereotypy by blockingNA synthesis (Spector et al. 1965) Lithium inrases deaminated catechols and reduces normetanephrine (Schildkraut, Schanberg & Kopin 1966) i.e.favours MAO attack
Correlates-urine NA raised in concrete threat, anger, activity A raisd in uncertainty, anxiety, inactivity (Elmadjian et al. 1957 , von Euler & Lundberg 1954 NA raised in mania (Strom-Olsen & Weil-Malberbe 1958) NA equivocal in depression (Bergsman 1959 , Curtisetal. 1960 Normetanephrine raised after successful imipramine (Schildkiraut 1965 , Schildkraut, Green, Gordon & Durrell 1966 Correlatesbrain BBB preventsentry to brain (Raab & Gigee 1951 , Schayer 1951 , Axelrod etal. 1959 , Weil-Malheibe 1960 'Cold' emotion (Maranon 1924) Effects depend on otherfactors (Schachter & Singer 1962) . NA should have greater effect than A according to theory Ineffective as mood elevator (Pare & Sandler 1959 , Klerman et al. 1963 5-HTPineffective as mood elevator (Kline et al.-1964) MAOI increase 5-HT more and T more still ? Peripheral action ofNA ? T levels Imipramine also affects otber amines e.g. potentiates 5-HT (Gyermek & Possemato 1960) Reserpine sedation attributed to NA depletion Amphetamine effective afterreserpinization (Gelder & Vane 1962) and supposed depleion ofNA Amphetamine and NA have opposing actions in CNS (Krnjevic &Phillis 1963 , Dewhurst & Marley 1964 , Fischer et al. 1964 Other amines also depleted e.g. 5-HT (Pletcher et al. 1956) Chlorpromazine also blocks ifintrastriatal (Fog et al. 1968) i.e. stereotypy striataland unrelated to mood Probably similar effects on other amines NA and A do not pass BBB (vide supra). Therefore changes indicate extracerebral activity e.g. in muscles (Karki 1956) Other amines also increased High NA output reported in psychotic depression and attributed to depression (Bunne et al. 1967) Normetanephrine does not pass BBB (Glowinski 6t al. 1965) and above commetits again apply Brain NA normal in suicides (Bourne et al. 1968) adrenaline from attack by monoamine oxidase, and amphetamine may have a similar action and is also thought to liberate noradrenaline. The euphoriant action of tryptophan is postulated as due to noradrenaline release occasioned by 5-HTP (although we have already noted that 5-HTP is ineffective in depression).
Turning to mood lowering agents, reserpine and tetrabenazine may be followed by depression which is attributed to depletion of noradrenaline (although again other amines are also affected). However, reserpine, combined with monoamine oxidase inhibitors or with imipramine, supposedly alleviates depression by potentiation of noradrenaline release. The disparity between this explanation and the one advanced for reserpine alone may be noted. a-methyl tyrosine blocks amphetamine stereotypy, it is argued, by inhibiting noradrenaline synthesis (although direct antagonism of receptors is one of several alternative explanations). Lithium favours access of noradrenaline to monoamine oxidase (but again other amines may also be affected).
Studies of urinary levels are quoted which indicate that noradrenaline excretion (+ adrenaline) is raised in states where there is a concrete threat with anger and activity. Adrenaline excretion only is raised in states of uncertainty with anxiety and inactivity. In mania noradrenaline excretion is increased and in depression it is described as equivocal. However, it has recently been reported (Bunney et al. 1967 ) that extremely high levels of noradrenaline occur in 'psychotic depression' which is attributed to the massive and prolonged psychological distress in the psychotically depressed individual. Schildkraut also cites the effects of successful imipramine treatment in which a low normetanephrine output increases with recovery. Again other amines, e.g. tryptamine, behave similarly after successful treatment and the findings in treated mania and depression almost certainly reflect activity of Table 3 Type A hypothesis of affective illness
Effectsexogenous amines
Type A amines elevate mood in man (e.g. amphetamine) Specific A receptor antagonist blocks such effects (Dewhurst 1968b) Effectsexogenous precursors Tryptophan euphoriant (Smith & Prockop 1962) Tryptophan ? counteracts reserpine Effectsmood elevating drugs affecting endogenous amines MAOIs elevate brain tryptamine (Hess et al. 1959) MAOIs cause greater increases than 5-HT or catechols Imipramine reduces cell uptake of amines (and hence MAO destruction) Reserpine + imipramine improve depression (Haskovec & Rysanek 1967) Amphetamine effect direct on receptor (Dewhurst & Marley 1964 Effectsmood lowering drugs affecting erdogenous amines All amines released by reserpine and tetrabenazine (Pletscher et al. 1955) Lithium increases deaminated and reduces methoxylated catechols (Schildkraut, Green, Gordon & Durrell 1966) i.e. favours access to MAO Mania stopped by methysergide (Dewhurst 1968c , Haskovec & Soucek 1968 Correlatesurine Tryptamine excretion low in depression (Rodnight 1961) e Phenylethylamine excretion low in depresson (Fischer et al. 1968) J Tryptamine excretion raised after successful ECT (Coppen, Shaw, Malleson, Eccleston & Gundy 1965) F Phenylethylamine excretion raised after MAOI (Fischer et al. 1968) Tryptamine low or raised in mania (Coppen 1967) Correlatesbrain ? Low levels Tryptamine has no effect intravenously (Coppen, Shaw, Malleson, Eccleston & Gundy 1965) ? Stability in solution 5-HTP ineffective so cannot be due to 5-HT (Pare & Sandler 1959 , Kline et al. 1964 Euphoria correlates with formation of unhydroxylated indoles and wanes when 5-hydroxylated indoles increase (Dewhurst 1965) Hydroxylated amines catabolized by 0-methylation Above factors again operate All amines released but MAOI affects unhydroxylated most Acts after reserpinization (Gelder & Vane 1962) Amine effects not separable Therefore unhydroxylated amines most affected (vide supra) Specific A receptor antagonist 5-HT low also (Rodnight 1961) Peripheral activity increases on recovery
Reflects patients' activity and metabolism
Small amounts oftryptamine and phenylethylamine will be very difficult to detect peripheral tissues. Finally, some of the National Institutes of Mental Health group in collaboration with Carshalton workers have reported that brain noradrenaline is normal in suicides assumed depressive.
To summarize, there is no clear evidence that cerebral actions of exogenous amines or precursors have an effect on mood nor that drugs which elevate or depress mood have significantly selective effects on noradrenaline rather than on other amines (indeed the reverse is the case). Because of blood-brain barrier considerations urinary results must reflect peripheral activity and in the only brain study done noradrenaline was found to be normal. It is particularly important not to equate peripherally induced arousal with euphoria.
Dysfunction ofType A Mechanism
By logical extension of the physiology noted earlier the following hypothesis has been derived: 'Lowering of mood and some forms of depressive illness may be due to either deficiency of excitant (Type A) amines, or diminished responsiveness of the A receptor. Psychosocial factors are codeterminants of complex behavioural responses. Elevation of mood and some manic states may be caused by an excess of excitant (Type A) amines or increased A receptor sensitivity. Psychosocial factors are co-determinants of more complex behavioural features (Dewhurst 1968a) .
In contrast to the two previous views both receptor dysfunction and psychosocial determinants are novelties but are empirically based on experiment and reinforced by clinical experience. Nothing is said about the depressant amines (in physiological terms) for there is no evidence linking them with mood.
Taking the evidence as before (Table 3) , we note that a number of amines acting on the A receptor such as amphetamine, phenmetrazine (Preludin), a-ethyl tryptamine (Monase), tranylcypromine (Parnate), have euphoriant effects in man. It should be noted that these effects occur before any inhibition of MAO in the case of Monase and Parnate, i.e. they are due to direct action on the receptor. All these substances pass the bloodbrain barrier. It is true that tryptamine had been administered intravenously without effect but its instability in aqueous solution particularly at pH 7-4 may perhaps be responsible. The amino acid precursor, tryptophan, may also be given and its euphoriant action seems well-established. Its effects are difficult to explain in terms of 5-HT because 5-HTP is ineffective.
The antidepressant action of monoamine oxidase inhibitors as we have seen is attributed to serotonin by some and noradrenaline by others. I am going t-o attribute it to tryptamine on the following grounds. Simultaneous measurements of the three main brain substrates of the enzyme in urine done before and after an amino oxidase inhibitor (phenelzine) showed differential effects. Tryptamine was quadrupled, 5-HT was not quite trebled and meta-and normeta-nephrine showed less increase still . There is a perfectly logical explanation for this. The two substrates showing least change can also be metabolized by 0-methylation whereas tryptamine cannot, and hence is much more sensitive to interference with MAO. It should also be noted that these changes occur wherever the inhibitor penetrates (both inside the brain and outside); however, tryptamine, unlike the others, can pass the blood-brain barrier so that not only is tryptamine the dominant physiological change in brain metabolism but the quantitatively large amounts of tryptamine occurring in extracerebral tissues will also contribute to cerebral effects.
As to otherantidepressants, imipramine as noted hinders access to MAO of various amines and it again follows that the amines mainly dependent on this route of catabolism will be affected most. The same is true for a combination of reserpine and MAOI and reserpine and imipramine. The action of amphetamine is a direct one on the receptor and this explains why it acts after reserpination.
Mood lowering agents comprise reserpine, which in this connexion does not favour one theory over another. On the other hand, lithium, favouring attack by MAO will again have most effect on the amines having no other route of catabolism. Finally, the prediction that methysergide would be effective has been verified and will be dealt with shortly.
Correlation studies in affective states show that although urinary tryptamine is low in depression, it rises after successful treatment and may or may not be elevated in mania. As before, I believe these effects reflect the peripheral tissue activity associated with the different illnesses rather than the cerebral happenings. We have no present evidence on cerebral levels partly because the normal amounts occurring in brain are difficult enough to detect in ordinary circumstances and consequently are likely to be even more difficult to estimate accurately if they are low (as I would predict) in depressive states. However, Bjorklund et al. (1968) have recently developed an elegant histofluorescent technique for tryptamine which is very sensitive and specific. Results of its application are eagerly awaited. It will thus be seen that despite newness a respectable amount of evidence may already be cited in support. Further, unlike the other two hypotheses, it has enabled predictions to be made which have been successfully verified. One such prediction is that the specific antagonist of the A receptor should benefit patients with mania. Two independent trials have confirmed this prediction. It is becoming clear that problems of absorption and destruction in the liver make for difficulties with oral administration unless the liver enzyme is inhibited by a fortnight's chlorpromazine, but the reality and specificity of the effects of methysergide seem undoubted. An explanation has also been proposed for a common mode of action for lithium and methysergide (Dewhurst 1969) .
Conclusion
The views expressed are believed to have a sound physiological basis and the logical bridges to clinical application have been empirically validated. Thus mood, which by definition is subjective, is beginning to yield its secrets to the objective methods of science which many have abandoned as inadequate or inappropriate to the task. Patients, however, are concerned not with epistemology but with recovery and it is hoped that these views may commend themselves as a way of furthering that end. Meeting February 11 1969 Ethology and Behaviour [Abridged] Dr John S Price (The Bethlem Royal and Maudsley Hospitals, London)
The Ritualization of Agonistic Behaviour as a Determinant of Variation along the Neuroticism/Stability Dimension of Personality When two individuals have had a serious fight over some prize, the loser is likely to be dead, or unconscious, or physically incapacitated or suffering such physical pain that the winner is able to take the prize without further interference. But serious fighting is rare in nature. Comparative ethologists have shown that, in most vertebrate species, disputes between individuals are settled by ritual fighting in which neither of the contestants is seriously harmed. If there is no physical incapacity or physical pain, what induces the loser in a ritual combat to yield the prize to the winner? One possibility is that ritual yielding is subserved by mental incapacity and mental pain.
If so, it would appear that ethologists have provided at least one important biological function for that puzzling phenomenon, the human neurotic reaction. Human neurotic reactions, characterized by depression, anxiety and lack of self-confidence, are both painful and incapacitating. The hypothesis that these reactions have evolved as the yielding component of ritual agonistic behaviour is attractive on two counts. First, the hypothesis predicts that behaviour analogous to the human neurotic reaction occurs in all species in which agonistic behaviour is ritualized, and thus indicates a wealth of animal models for the study of human neurosis. Secondly, it provides some suggestions for prophylaxis and treatment.
The hypothesis is consistent with, and complementary to, many clinical observations about human states of depression and anxiety, observations which relate these morbid states to competition between individuals. Freud stressed the competition between father and son over the
